Enhanced Insulin Production From Porcine Islets: More Insulin, Less Islets.

Area of Science:

• Biotechnology
• Transplantation Immunology
• Endocrinology

Background:

• Clinical pancreatic islet xenotransplantation necessitates genetically modified pigs to overcome immune rejection and ensure graft function.
• Current modifications focus on mitigating host immune responses, but intrinsic islet secretory function remains a challenge.
• Porcine islets exhibit suboptimal insulin secretion, often requiring large transplant volumes.

Purpose of the Study:

• To develop a new line of transgenic pigs with enhanced beta-cell secretory function for improved islet xenotransplantation outcomes.
• To investigate the efficacy of activating specific secretory amplifying pathways in porcine beta-cells.

Main Methods:

• Creation of transgenic pigs with targeted activation of beta-cell secretory pathways.
• Assessment of insulin secretion from isolated islets (in vitro) and after transplantation (in vivo) in diabetic mouse models.

Main Results:

• Transgenic porcine islets demonstrated superior insulin secretion compared to wild-type islets in native pancreas, in vitro, and in vivo.
• Transplanted islets from the new transgenic line successfully improved glycemic control in diabetic mice.

Conclusions:

• Activating specific secretory pathways in porcine beta-cells significantly enhances insulin secretion.
• This genetic modification represents a promising advancement for improving the efficacy of pancreatic islet xenotransplantation in treating diabetes.